Hikma Pharmaceuticals PLC (HKMPF)
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
$21.56+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-18.3%
The outlook
Hikma Pharmaceuticals PLC currently reads as leaning bullish based on above its 50- & 200-day averages, 52% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Market cap
$4.50B
52-wk high
$26.38
52-wk low
$16.34
50-day avg
$19.97
200-day avg
$20.09
Trailing P/E
11.9